Cobamamide clinical trials
How each study uses cobamamide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the cobamamide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- adenosylcobalamin
- 2
Studies by the year they started
3 studies that test it; most in 2012 (1)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 2
HanAll BioPharma Co., Ltd. (1) · Tongji Hospital (1) · Fakultas Kedokteran Universitas Indonesia (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test cobamamide.
- Jul 2027A Study on the Safety and Efficacy of Adenosylcobalamin in Patients With Declining Ovarian FunctionPhase 4 · Tongji Hospital
Studies
Open first, then newest update. How each study uses cobamamide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Study on the Safety and Efficacy of Adenosylcobalamin in Patients With Declining Ovarian FunctionNot yet recruitingPhase 4Tongji HospitalNCT07947680Written as adenosylcobalaminHow we know
- The Role of Cobamamide Supplements in Malnourished PatientsNot yet recruitingNot applicableFakultas Kedokteran Universitas IndonesiaNCT05944744Written as AdenosylcobalaminHow we know
- Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic DermatitisCompletedPhase 2HanAll BioPharma Co., Ltd.NCT01568489Written as HL-009 Liposomal GelHow we know
What changed recently
From the registry's own updates since Oct 22, 2026.
Newly registered1
Codes
What other systems call cobamamide · ClinicalTrials.gg INT002227
- MeSH (NLM) C000913cobamamideOne source NLM
- UNII (FDA) F0R1QK73KBCOBAMAMIDEConfirmed FDA, NLM, Wikidata
- RxNorm 21373Confirmed FDA, Wikidata
- Wikidata Q239593cobamamideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C169859CobamamideOne source FDA
- DrugBank DB11191One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000913 | cobamamide | One source NLM |
| UNII (FDA) | F0R1QK73KB | COBAMAMIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 21373 | — | Confirmed FDA, Wikidata |
| Wikidata | Q239593 | cobamamide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C169859 | Cobamamide | One source FDA |
| DrugBank | DB11191 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.